PD-090560

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePD-090560
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsRejection of organ transplantationAtherosclerosisCoronary Restenosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAtherosclerosisCoronary Restenosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A